ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

NCI To End CIS Partnership Program In 2010.

December 5, 2008

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

NCAB To Hear Details Of New Grant Program, Hanna’s Frederick Plans

November 15, 1974